Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC6A2 | P23975 | 12/20 | 0.31 |
| ▸ | SLC6A4 | P31645 | 12/20 | 0.31 |
| ▸ | SLC6A3 | Q01959 | 12/20 | 0.31 |
| ▸ | CYP2D6 | P10635 | 7/20 | 0.31 |
| ▸ | CYP2C19 | P33261 | 5/20 | 0.31 |
| ▸ | KCNH2 | Q12809 | 5/20 | 0.31 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.31 |
| ▸ | CHRM3 | P20309 | 2/20 | 0.30 |
| ▸ | MAPK8 | P45983 | 1/20 | 0.30 |
| ▸ | MAPK9 | P45984 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2805222 | 0.94 | CHEK1 (0.32) | SLC6A2SLC6A4SLC6A3CYP2D6CYP2C19 | |
| SCHEMBL2808570 | 0.93 | FPR2 (0.33) | SLC6A2SLC6A4SLC6A3CYP2D6CYP2C19 | |
| SCHEMBL2803262 | 0.92 | CHEK1 (0.36) | CYP2C19CYP3A4CHRM3MAPK8MAPK9 | |
| SCHEMBL2804693 | 0.90 | ALDH1A1 (0.36) | SLC6A2SLC6A4SLC6A3CYP2D6CYP2C19 | |
| SCHEMBL2803902 | 0.88 | CYP2C19 (0.34) | SLC6A2SLC6A4SLC6A3CYP2D6CYP2C19 | |
| SCHEMBL2802547 | 0.88 | RAB9A (0.35) | SLC6A2SLC6A4SLC6A3CYP2C19CYP3A4 | |
| SCHEMBL2804448 | 0.87 | GOT1 (0.38) | — | |
| SCHEMBL2805160 | 0.87 | ALDH1A1 (0.34) | KCNH2CHRM3 | |
| SCHEMBL2802823 | 0.86 | SLC6A4 (0.35) | SLC6A2SLC6A4SLC6A3 | |
| SCHEMBL2806246 | 0.86 | CYP1A2 (0.39) | CYP2C19CYP3A4MAPK8MAPK9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2379506-B1 | SUBSTITUTED 5,6-DIHYDRO-6-PHENYLBENZO[F]ISOQUINOLIN-2-AMINE COMPOUNDS | ARQULE INC (US) | 2015-09-02 | — | — | EP | disclosed |
| EP-2379506-B1 | SUBSTITUTED 5,6-DIHYDRO-6-PHENYLBENZO[F]ISOQUINOLIN-2-AMINE COMPOUNDS | ARQULE INC (US) | 2015-09-02 | — | — | EP | disclosed |
| US-8357694-B2 | Substituted 5,6-dihydro-6-phenylbenzo[F]isoquinolin-2-amine compounds | ARQULE, INC. (US) | 2013-01-22 | — | — | US | disclosed |
| US-8357694-B2 | Substituted 5,6-dihydro-6-phenylbenzo[F]isoquinolin-2-amine compounds | ARQULE, INC. (US) | 2013-01-22 | — | — | US | disclosed |
| US-20100239525-A1 | SUBSTITUTED 5,6-DIHYDRO-6-PHENYLBENZO[F]ISOQUINOLIN-2-AMINE COMPOUNDS | ARQULE, INC. (US) | 2010-09-23 | — | — | US | disclosed |
| WO-2010078421-A1 | SUBSTITUTED 5,6-DIHYDRO-6-PHENYLBENZO[F] ISOQUINOLIN-2-AMINE COMPOUNDS | ARQULE, INC. (US) | 2010-07-08 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100239525-A1 | SUBSTITUTED 5,6-DIHYDRO-6-PHENYLBENZO[F]ISOQUINOLIN-2-AMINE COMPOUNDS | NQO1, DPYD, H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16 | SLC6A2 233/4885SLC6A4 564/4885SLC6A3 707/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.